Rep. Mark Pocan @RepMarkPocan
Capping insulin costs at $35 a month for seniors was a key provision of the Inflation Reduction Act. Now, @LillyPad is announcing they are capping costs for more insulin users. Good policy pushes companies to do the right thing. https://t.co/6UPfc2zm0D — PolitiTweet.org